Q1: 2026-05-13 Earnings Summary
EPS of $0.49 beats by $0.02
|
Revenue of
$6.01B
(1.82% Y/Y)
beats by $60.82M
Merck KGaA (MKKGY) Q1 2026 Earnings Call May 13, 2026 8:00 AM EDT
Company Participants
Florian Schraeder - Head of Investor Relations
Kai Beckmann - CEO & Chair of Management Board
Helene von Roeder - CFO & Member of Executive Board
Jean-Charles Wirth
Danny Bar-Zohar - Member of the Executive Board & CEO of Healthcare
Amy Kao
Benjamin Hein - Head of Life Science
Conference Call Participants
Richard Vosser - JPMorgan Chase & Co, Research Division
Sachin Jain - BofA Securities, Research Division
Peter Verdult - BNP Paribas, Research Division
Matthew Weston - UBS Investment Bank, Research Division
James Quigley - Goldman Sachs Group, Inc., Research Division
Charles Pitman - Barclays Bank PLC, Research Division
Oliver Metzger - ODDO BHF Corporate & Markets, Research Division
Falko Friedrichs - Deutsche Bank AG, Research Division
Thibault Boutherin - Morgan Stanley, Research Division
Rajesh Kumar - HSBC Global Investment Research
Simon Baker - Rothschild & Co Redburn, Research Division
Peter Spengler - DZ Bank AG, Research Division
Presentation
Operator
Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on First Quarter 2026. [Operator Instructions] I'm now handing over to Florian Schraeder, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.
Florian Schraeder
Head of Investor Relations
Thank you, Sarah. Highly appreciate everyone joining us for our Q1 '26 earnings call. My name is Florian Schraeder, and I'm the Head of Investor Relations at Merck. I am delighted to be joined by Kai Beckmann, our Group CEO; and Helene von Roeder, Group CFO. Kai and Helene will walk us through the key slides and financial highlights of the past quarter. And Kai will also take the opportunity to provide an update on the company's strategic direction.
For the Q&A part of the call, we will be further joined by Jean-Charles Wirth, CEO of Life Science; Danny Bar-Zohar, CEO of Healthcare; and Benjamin Hein, CEO of
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。